These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 34085362)
21. BRCA1 and BRCA2 risk perceptions among African American women at increased risk for hereditary breast-ovarian cancer. Kessler L; Domchek S; Stopfer J; Halbert CH Community Genet; 2008; 11(4):193-200. PubMed ID: 18417966 [TBL] [Abstract][Full Text] [Related]
22. Development and pilot testing of a training for bilingual community education professionals about hereditary breast and ovarian cancer among Latinas: ÁRBOLES Familiares. Vadaparampil ST; Moreno Botero L; Fuzzell L; Garcia J; Jandorf L; Hurtado-de-Mendoza A; Campos-Galvan C; Peshkin BN; Schwartz MD; Lopez K; Ricker C; Fiallos K; Quinn GP; Graves KD Transl Behav Med; 2022 Jan; 12(1):. PubMed ID: 34255089 [TBL] [Abstract][Full Text] [Related]
24. Active approach for breast cancer genetic counseling during radiotherapy: long-term psychosocial and medical impact. Baars JE; Bleiker EM; van Riel E; Rodenhuis CC; Velthuizen ME; Schlich KJ; Ausems MG Clin Genet; 2014 Jun; 85(6):524-31. PubMed ID: 24372530 [TBL] [Abstract][Full Text] [Related]
25. Correlates of Adjuvant Therapy Attitudes in African American Breast Cancer Patients. Edmonds MC; Sutton AL; He J; Perera RA; Sheppard VB J Natl Med Assoc; 2020 Apr; 112(2):167-175. PubMed ID: 32197898 [TBL] [Abstract][Full Text] [Related]
26. Intentions for risk-reducing surgery among high-risk women referred for BRCA1/BRCA2 genetic counseling. Tong A; Kelly S; Nusbaum R; Graves K; Peshkin BN; Valdimarsdottir HB; Wood M; McKinnon W; Garber J; McCormick SR; Jandorf L; Schwartz MD Psychooncology; 2015 Jan; 24(1):33-9. PubMed ID: 24839250 [TBL] [Abstract][Full Text] [Related]
27. BRCA1/2 testing in hereditary breast and ovarian cancer families: effectiveness of problem-solving training as a counseling intervention. McInerney-Leo A; Biesecker BB; Hadley DW; Kase RG; Giambarresi TR; Johnson E; Lerman C; Struewing JP Am J Med Genet A; 2004 Oct; 130A(3):221-7. PubMed ID: 15378542 [TBL] [Abstract][Full Text] [Related]
29. Genetic counseling and testing for breast cancer risk in African Americans. Halbert CH LDI Issue Brief; 2006 Sep; 12(1):1-4. PubMed ID: 17302016 [TBL] [Abstract][Full Text] [Related]
30. Genetic counseling, testing, and screening for breast and ovarian cancer: practical and social considerations. Khabele D; Runowicz CD Curr Womens Health Rep; 2002 Jun; 2(3):163-9. PubMed ID: 12099190 [TBL] [Abstract][Full Text] [Related]
31. Awareness and preferences regarding BRCA1/2 genetic counseling and testing among Latinas and non-Latina white women at increased risk for hereditary breast and ovarian cancer. Gammon AD; Rothwell E; Simmons R; Lowery JT; Ballinger L; Hill DA; Boucher KM; Kinney AY J Genet Couns; 2011 Dec; 20(6):625-38. PubMed ID: 21691939 [TBL] [Abstract][Full Text] [Related]
32. Influence of race/ethnicity on genetic counseling and testing for hereditary breast and ovarian cancer. Forman AD; Hall MJ Breast J; 2009; 15 Suppl 1():S56-62. PubMed ID: 19775331 [TBL] [Abstract][Full Text] [Related]
33. BRCA1/2 testing in hereditary breast and ovarian cancer families II: impact on relationships. McInerney-Leo A; Biesecker BB; Hadley DW; Kase RG; Giambarresi TR; Johnson E; Lerman C; Struewing JP Am J Med Genet A; 2005 Mar; 133A(2):165-9. PubMed ID: 15633195 [TBL] [Abstract][Full Text] [Related]
34. Women's satisfaction with genetic counseling for hereditary breast-ovarian cancer: psychological aspects. Tercyak KP; Demarco TA; Mars BD; Peshkin BN Am J Med Genet A; 2004 Nov; 131(1):36-41. PubMed ID: 15389697 [TBL] [Abstract][Full Text] [Related]
35. Use of a Standardized Tool to Identify Women at Risk for Hereditary Breast and Ovarian. Hessock M; Brewer T; Hutson S; Anderson J Nurs Womens Health; 2021 Jun; 25(3):187-197. PubMed ID: 33933425 [TBL] [Abstract][Full Text] [Related]
36. Insights into BRCA1/2 Genetic Counseling from Ethnically Diverse Latina Breast Cancer Survivors. Rajpal N; Muñoz J; Peshkin BN; Graves KD J Genet Couns; 2017 Dec; 26(6):1221-1237. PubMed ID: 28374142 [TBL] [Abstract][Full Text] [Related]
37. Knowledge, attitudes, and interest in breast-ovarian cancer gene testing: a survey of a large African-American kindred with a BRCA1 mutation. Kinney AY; Croyle RT; Dudley WN; Bailey CA; Pelias MK; Neuhausen SL Prev Med; 2001 Dec; 33(6):543-51. PubMed ID: 11716649 [TBL] [Abstract][Full Text] [Related]
38. Why Is Cancer Genetic Counseling Underutilized by Women Identified as at Risk for Hereditary Breast Cancer? Patient Perceptions of Barriers Following a Referral Letter. Kne A; Zierhut H; Baldinger S; Swenson KK; Mink P; Veach PM; Tsai ML J Genet Couns; 2017 Aug; 26(4):697-715. PubMed ID: 27826805 [TBL] [Abstract][Full Text] [Related]
39. Healthcare Predictors of Information Dissemination About Genetic Risks. Henderson V; Strayhorn SM; Bergeron NQ; Strahan DC; Ganschow PS; Khanna AS; Watson K; Hoskins K; Molina Y Cancer Control; 2022; 29():10732748221104666. PubMed ID: 35658635 [TBL] [Abstract][Full Text] [Related]